Repligen (RGEN) Other Non-Current Liabilities (2011 - 2026)
Repligen (RGEN) posted quarterly Other Non-Current Liabilities of $17.1 million for Q2 2026, up 1.31% year-over-year from $16.9 million in Q2 2025, and up 2.0% quarter-over-quarter from $16.8 million in Q1 2026.
Repligen (RGEN) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Other Non-Current Liabilities for 16 consecutive years, with $17.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non-Current Liabilities rose 1.31% year-over-year to $17.1 million; the TTM figure through Jun 2026 stood at $17.1 million (up 1.31% YoY), while the FY2025 annual figure was $15.6 million, down 57.72% from the prior year.
- Other Non-Current Liabilities grew to $17.1 million in Q2 2026 per RGEN's latest filing, from $16.8 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $69.1 million in Q3 2022 and bottomed at $11.3 million in Q1 2024.
- Historically, Other Non-Current Liabilities has averaged $29.7 million across 5 years, with a median of $17.1 million in 2025.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities surged 4515.7% — and 2023, when it sank 80.1%.
- Repligen's Other Non-Current Liabilities stood at $51.6 million in 2022, then tumbled by 72.71% to $14.1 million in 2023, then soared by 161.46% to $36.8 million in 2024, then sank by 57.72% to $15.6 million in 2025, then gained by 9.87% to $17.1 million in 2026.
- Business Quant data shows RGEN's Other Non-Current Liabilities at $17.1 million in Q2 2026, $16.8 million in Q1 2026, and $15.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.09 Mn |
| Mar 31, 2026 | 16.76 Mn |
| Dec 31, 2025 | 15.56 Mn |
| Sep 30, 2025 | 17.32 Mn |
| Jun 30, 2025 | 16.87 Mn |
| Mar 31, 2025 | 17.08 Mn |
| Dec 31, 2024 | 36.79 Mn |
| Sep 30, 2024 | 11.61 Mn |
| Jun 30, 2024 | 11.48 Mn |
| Mar 31, 2024 | 11.28 Mn |
| Dec 31, 2023 | 14.07 Mn |
| Sep 30, 2023 | 13.76 Mn |
| Jun 30, 2023 | 44.28 Mn |
| Mar 31, 2023 | 38.91 Mn |
| Dec 31, 2022 | 51.56 Mn |
| Sep 30, 2022 | 69.14 Mn |
| Jun 30, 2022 | 67.90 Mn |
| Mar 31, 2022 | 64.04 Mn |
| Dec 31, 2021 | 94.24 Mn |
| Sep 30, 2021 | 79.96 Mn |